Skip to main content


IRAZÚ Bio-Holdings

IRAZÚ Bio-Holdings de-risks, translates and increases the value of intellectual property assets, while bridging the uncertainty divide between academic research and drug development. IRAZÚ incubates early stage ideas through preclinical proof of concept studies and into Phase 1 clinical trials. Promising technologies will be spun off either as new companies or through licensing agreements with pharmaceutical and biotechnology companies.


Contact Name: 
Katie Kirsch
Director of Communications and Business Development
801 W. Baltimore St.
Suite 520
Baltimore  Maryland  21201
United States